MS
ABBV icon

Madden Securities’s AbbVie ABBV Stock Holding History

Madden Securities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.71M Sell
10,775
-450
-4% -$96.8K 0.75% 37
2026
Q1 		$2.44M Hold
11,225
– – 0.73% 36
2025
Q4 		$2.56M Sell
11,225
-230
-2% -$52.4K 0.78% 36
2025
Q3 		$2.65M Sell
11,455
-198
-2% -$40.3K 0.81% 33
2025
Q2 		$2.16M Sell
11,653
-202
-2% -$37.5K 0.73% 36
2025
Q1 		$2.48M Hold
11,855
– – 0.96% 30
2024
Q4 		$2.11M Sell
11,855
-475
-4% -$87.3K 0.84% 35
2024
Q3 		$2.43M Sell
12,330
-455
-4% -$84.9K 1.05% 27
2024
Q2 		$2.19M Sell
12,785
-30
-0.2% -$4.97K 0.97% 29
2024
Q1 		$2.33M Sell
12,815
-215
-2% -$37.1K 1.08% 28
2023
Q4 		$2.02M Sell
13,030
-1,253
-9% -$183K 1.07% 29
2023
Q3 		$2.13M Sell
14,283
-120
-0.8% -$17.6K 1.2% 29
2023
Q2 		$1.94M Buy
14,403
+103
+0.7% +$15.1K 0.99% 31
2023
Q1 		$2.28M Sell
14,300
-164
-1% -$25.1K 1.21% 26
2022
Q4 		$2.34M Sell
14,464
-1,351
-9% -$207K 1.23% 25
2022
Q3 		$2.12M Sell
15,815
-96
-0.6% -$13.8K 1.28% 28
2022
Q2 		$2.44M Sell
15,911
-23,859
-60% -$3.65M 1.34% 29
2022
Q1 		$6.45M Sell
39,770
-1,091
-3% -$158K 2.91% 9
2021
Q4 		$5.53M Buy
40,861
+905
+2% +$107K 2.59% 9
2021
Q3 		$4.31M Buy
39,956
+9,265
+30% +$1.06M 2.33% 10
2021
Q2 		$3.46M Buy
30,691
+30
+0.1% +$3.38K 1.81% 16
2021
Q1 		$3.32M Buy
30,661
+4,891
+19% +$523K 1.94% 14
2020
Q4 		$2.76M Buy
25,770
+1,923
+8% +$185K 1.78% 14
2020
Q3 		$2.09M Buy
23,847
+5,324
+29% +$501K 1.55% 15
2020
Q2 		$1.82M Buy
+18,523
New +$1.63M 1.62% 17
2019
Q4 		$559K Buy
+6,310
New +$524K 0.56% 52

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Madden Securities's ABBV Position: Q2 2026 in Review

Madden Securities reduced its AbbVie (ABBV) stake by 4% in Q2 2026, selling an estimated $96.8K and leaving 10,775 shares worth $2.71M. The position accounts for 0.75% of the portfolio, ranked #37.

Madden Securities first reported a position in ABBV in Q4 2019 and has held it in 26 quarters since. The position peaked at $6.45M in Q1 2022. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Madden Securities held 10,775 shares of AbbVie worth $2.71M as of Q2 2026.
  • Madden Securities sold 450 AbbVie shares in Q2 2026, an estimated $96.8K.
  • AbbVie made up 0.75% of Madden Securities's portfolio in Q2 2026, its #37 holding.
  • Madden Securities first reported a position in AbbVie in Q4 2019 and has held it in 26 quarters since.
  • Madden Securities's AbbVie position peaked at $6.45M in Q1 2022.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Madden Securities's 13F filing for Q2 2026, filed 24 Jul 2026.